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OL-040 Clinical and biological status of young adults
infected with HIV through mother-to-child
transmission (MTCT) or during infancy
Zhi-Tao Yang*,1,2, Frédéric Méchaï 1, Marie-Laure Chaix 3,
Laurent Roudière1, Chantal Rothschild4, Olivier Lortholary1,
Stéphane Blanche5, Jean-Paul Viard1. 1Service des Maladies
Infectieuses et Tropicales,Centre Hospitalier Universitaire
Necker-Enfants Malades; 2Emergency department, Ruijin
Hospital, Shanghai, China; 3Laboratoire de Virologie,Centre
Hospitalier Universitaire Necker-Enfants Malades; 4Centre de
Traitement de l’Hémophilie,Centre Hospitalier Universitaire
Necker-Enfants Malades; 5Unité d’Immuno-Hématologie
Pédiatrique, Centre Hospitalier Universitaire Necker-Enfants
Malades
Background: Subjects infected with HIV through MTCT or dur-
ing infancy, and now reaching adulthood, form an emerging,
little described population characterized by young age but long
exposure to HIV and antiretroviral therapy (ART).
Methods: Single-center review of patients transferred from pe-
diatrics to the adults department for HIV infection, last visit and
analysis at February 2008.
Results: 14/50 patients had experienced AIDS-deﬁning events
before transfer, with a mean CD4 nadir at 7.4±7.0% and a plasma
HIV RNA zenith at 4.9lg copies/ml. At the time of transfer, 49/50
patients were on ART, 40% of them had a viral load<1.6lg, and
mean CD4 was 423±291 (21.2%). Since transfer, 2 patients died,
10 AIDS-deﬁning events occurred in 5 patients, and 8 were lost
to follow-up. All events occurred in the 14 patients whose adher-
ence to ART was chronically poor. After a median follow-up of 5
years in the adults department, among the 40 patients regularly
attending visits, 90% had a Karnofsky index at 100% and 82.5%
were either employed or students; 72.5% had a viral load<1.6lg,
and the mean CD4 count was 559±350. Tolerance to ART was
generally good, but 4 patients had clinical lipodystrophy, 4 had
hyper-triglyceridemia and 7 had hypo-HDL cholesterolemia.
Conclusion: In this large cohort of young adults infected though
MTCT or during infancy, we found a good virological response
with undetectable viral load in 72.5% and high CD4 counts in
half of the patients. The issue of adherence is crucial in this
population.
OL-041 Non-cirrhotic portal hypertension (NCPHT) in 15
patients with HIV: characteristics, outcome and
prognosis
Aurélie Plessier *,1, Anne Gervais 2,3, Pierre Emmanuel Rautou1,
Hélène Labadi 4, Claire Francoz1, Francois Durand1, Dominique
Cazals Hatem5, Pierre Bedossa5, Violaine Ozenne1,
Sophie Hillaire6, Claude De Gennes2,7, Annie Lepretre2,3,
Pauline Campas2,8, Hugues Aumaitre2,9, C Picketty2,10,
Bertrand Condat1, Dominique Valla1. 1Hepatology Hopital
Beaujon; 2Maladies Infectieuses; 3Hopital Bichat; 4Hepatology
Hopital Saint Denis; 5Anatomo Pathology, Hopital Beaujon;
6Hepatology, Hopital Foch; 7Hoiptal Pitié salpétrière; 8Hopital
Saint Antoine; 9Hopital Perpignan; 10Hopital Georges Pompidou,
France
Background: Course, outcome and prognosis of non cirrhotic
portal hypertension (NCPHT) in patients with HIV infection need
to be clariﬁed.
Methods: Retrospective analyses of 15 patients with HIV and
NCPHT seen in 2003-2008 in a hepatology unit.
Results: 15 patients, aged 32-75 years (median 51 years),
followed-up 3-69 months (median 12 months) after diagnosis
of NCHPT. All had HIV associated obstructive portopathy on liver
biopsy. NCPHT was diagnosed 4-19 years (median 13 years) after
HIV infection, mean CD 4: 217±90, undetectable viral load.
Protein S deﬁciency was found in 7 patients, antiphospholipid
syndrome in 1. Median platelets were 132×109/l (71-226), ASAT
55 UI (32-125), and Child-Pugh score 6 (5-9). Twelve patients had
oesophageal varices, 8 variceal bleeding, 2 rebleeding despite
beta blockers. Eight patients thrombosed the portal vein, and
1 the mesenteric vein, were treated with anticoagulation. One
year transplant-free and overall survival rates were 75% and
81%, respectively. Patients with an unfavourable outcome (trans-
plantation or death) had more frequently ascites (3/3 vs. 2/12;
p=0.022), Child-Pugh score B or C. (3 of 3, vs. 0 of 12; p=0.002)
and lower body mass index (13±0 vs. 20.8±2.5; p=0.033).
Conclusion: NCPHT is a potentially fatal disease occurring late in
the course of HIV infection. Liver transplantation should rapidly
be considered in patients with ascites, Child Pugh score B or
C, or undernutrition. Close surveillance is necessary for early
detection of portal vein thrombosis.
OL-042 Asymptomatic bacterial STD screening:
experience from an inner city HIV clinic
Adetunji Adejumo*, Wafaar El-Sadr, Sharon Mannheimer. Div. of
Infectious Disease, Dept. of Medicine, Harlem Hosp Ctr.,
Columbia University, New York, USA
Background: Sexually transmitted diseases (STDs) can serve as
cofactors for HIV transmission. In this report we describe the in-
cidence of bacterial STDs identiﬁed through a screening program
conducted among HIV-infected individuals.
Methods: Screening was done for Neisseria gonorrhea (GC),
Chlamydia trachomatis (CT), and Treponema pallidum (syphilis).
GC/CT screening was performed on urine by ampliﬁed DNA assay
(BD ProbeTec™; Bacton, Sparks, MD). Syphilis testing was done by
IgG antibody with reﬂex testing of positive specimens for rapid
plasma reagin (RPR)/microhemagglutination assay treponema
pallidum (MHATP).
Results: A total of 1248 specimens for bacterial STDs were col-
lected from 793 adult HIV-infected patients (≥18 yrs) between
April 2007 and November 2008. Urine GC/CT testing was done on
217 (27.3%) patients. 5 (2.3% of 217 patients; 3 women, 2 men)
were positive for GC/CT with 4 of 5 positive for GC and 2 of 5
positive for CT.
Syphilis testing was performed on 780 patients, of whom 26.4%
(206/780) tested positive. Of the 206 with positive syphilis IgG
serology, 168 patients (81.5%) had a reactive MHATP, 61 patients
(29.6%) had a reactive RPR. The 61 patients with reactive RPR
included 39 men (64%) and 22 women (36%); mean age was 44 y
(range 19-77).
Conclusions: Two percent of HIV infected inner city population
had GC/CT infection detected by urine testing. Eight percent had
a reactive RPR for syphilis. Screening for bacterial STDs in this
inner city HIV clinic identiﬁed asymptomatic STDs, supporting
screening and treatment as one strategy for secondary HIV
prevention.
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OL-043 Passive immunotherapy for inﬂuenza A H5N1
virus infection with equine hyperimmune
globulin F(ab’)2 in mice
Juan Dai, Dingmei Zhang, Jiahai Lu*. Sun Yat-sen University
Background: Since 2003, there are total 38 human avian in-
ﬂuenza cases in China, 25 of them dead. To control the H5N1,
it is necessary to develop effective vaccine and drugs. To inves-
tigate the possible therapeutic effect of antibody against highly
pathogenic H5N1 virus on a mammal host, we prepared speciﬁc
equine anti-H5N1 IgGs from horses vaccinated with inactivated
H5N1 virus, and then obtained the F(ab’)2 fragments by pepsin
digestion of IgGs.
Method: The horses were vaccinated with inactivated H5N1 vac-
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cine to prepare anti-H5N1 IgGs. The F(ab’)2 fragments were
puriﬁed from anti-H5N1 hyperimmune sera by a protocol for
’enhanced pepsin digestion’. The protective effect of the F(ab’)2
fragments against H5N1 virus infection was determined in cul-
tured MDCK cells by cytopathic effect (CPE) assay and in a BALB/c
mouse model by survival rate assay.
Results: By the protocol for “enhanced pepsin digestion”, total
16 g F(ab’)2 fragments were ﬁnally obtained from one liter
equine antisera with the purity of over 90%. The H5N1-speciﬁc
F(ab’)2 fragments had a HI titer of 1:1024, and the neutralization
titre of F(ab’)2 reached 1:2048. The in vivo assay showed that
100 μg of the F(ab’)2 fragments could protect BALB/c mice
infected with a lethal dose of inﬂuenza H5N1 virus.
Conclusion: The availability of highly puriﬁed H5N1-speciﬁc
F(ab’)2 fragments may be promising for treatment of inﬂuenza
H5N1 infection. Our work has provided experimental support
for the application of the therapeutic equine immunoglobulin in
future large primate or human trials.
OL-044 Molecular evolution of H9N2 inﬂuenza A viruses
in Eastern China (1996 to 2008): implications for
the origin of highly pathogenic H5N1 viruses
Pinghu Zhang*,1,2, Xiufan Liu1, Yinghua Tang1, Xiaowen Liu1,
Wenbo Liu1, Xiaorong Zhang1, Hongqi Liu1, Daxin Peng1,
Song Gao1, Yantao Wu1, Shan Lu3,4. 1Animal Infectious Disease
Laboratory, College of Veterinary Medicine, Yangzhou
University; 2New Drug Screening Center, China Pharmaceutical
University; 3The First Afﬁliated Hospital of Nanjing Medical
University; 4University of Massachusetts Medical School,
Worcester, MA, USA
Background: Since it was ﬁrst isolated in Southern China in 1992,
H9N2 avian inﬂuenza virus has caused signiﬁcant economic loss in
China and is transmitted to humans and other animals. Currently,
H5N1 avian inﬂuenza virus have resulted in 285 deaths of 364
diagnosed humans cases. However, the precursors of these H5N1
inﬂuenza viruses are yet to be determined.
Methods: We analyzed the antigenic and genetic features of
H9N2 inﬂuenza viruses isolated from poultry in Eastern China
from 1996 to 2008.
Results: Phylogentic analysis revealed 6 genotypes, includ-
ing 4 novel genotypes that have not been recognized be-
fore. The major H9N2 inﬂuenza viruses represented by
A/Chiken/Beijing/1/1994 (Ck/BJ/1/94)-like viruses circulating
in poultry in eastern China before 1998 were gradually replaced
by A/Chicken/Shanghai/F/1998 (Ck/SH/F/98)-like viruses, which
contained RNP complex genes genetically highly related to H5N1
inﬂuenza virus, since1998. The similarity of the RNP genes in
Ck/SH/F/98-like viruses to those of the human and poultry H5N1
inﬂuenza viruses isolated from 2001 onwards circulating in Eura-
sia suggests that the Ck/SH/F/98 virus may have been the donor
of internal genes of these H5N1 viruses.
Conclusion: Our study provides new insights into the genesis and
evolution of H9N2 inﬂuenza viruses and provides new evidence
for the origin of H5N1 inﬂuenza viruses.
OL-045 The establishment of real-time ﬂuorescent
quantitative polymerase chain reaction (PCR) for
detection of highly pathogenic Avian inﬂuenza
virus subtype H5N1
Changran Zhang*,1, Yuanyuan Niu1, Xiaoyuan Liu1,
Kaiquan Zhou2, Jiancong Lin1, Ming Li 1, Xiaohua Luo2.
1Department of Internal Medicine, Huang Pu Hospital of the
First Afﬁliated Hospital, Sun Yat-sen University; 2The Huang Pu
Center of Disease Control and Prevention (CDC)
Background: Highly pathogenic strains of avian inﬂuenza virus
(AIV), which are inﬂuenza A viruses, cause severe disease in
domestic poultry and humans. The objective of this study was to
establish a ﬂuorescent quantitative RT-PCR assay for detection of
highly pathogenic avian inﬂuenza virus (AIV) subtype H5N1.
Methods: The H5 and N1 subtype-speciﬁc probe sets were de-
veloped based on avian inﬂuenza virus sequences detected in
China. Two pairs of primers and two ﬂuorescent probes were
strictly designed and optimized in a reaction system. According
to the amount of plasmid RNA extracted from H5N1 strains, the
standard curve DWQBGWDWQBGW of ﬂuorescent quantitative
PCR was drawn and all of the specimens were then tested by
means of Real-time PCR.
Results: The standard avian inﬂuenza A virus/H5N1 panel ap-
peared positive (10/10, 100%), which demonstrated by virus
isolation (VI). H9N2 and H3N2 were all negative (10/10, 100%);
Newcastle disease virus (NDV), infectious bronchitis virus (IBV),
infectious bursal disease virus (IBDV), egg drop syndrome virus
(EDSV), and the blank control were all negative (10/10, 100%).
11 sick or dying chickens, which were diagnosed AIV, appeared
positive (10/11, 90.9%); 65 staffs’ throat swab samples also were
collected who worked as sellers of chickens in the bird markets
were all negative (0/65,0%). The assay was easy to carry out and
highly reproducible.
Conclusion: Fluorescent quantitative PCR, described here, pro-
vides a rapid, speciﬁc and sensitive method to detect not only
the H5 but N1 genes as well, in particular, during outbreaks of
H5N1 inﬂuenza A virus.
OL-046 Comparative study of rapid test with standard
method RT-PCR for detection of inﬂuenza A virus
infection in suspected cases admitted at
Khonkaen Hospital, Thailand during 2005–2007
Pairoj Wechagama*, Wisansanee Thaewpia, Rinjong Promsorn,
Sompong Jinathongthai. Clinical Pathology Laboratory
Department, Khon Kaen Hospital, Khon Kaen, Thailand
Objectives: To assess the performance and effectiveness of rapid
test; Clearview Exact Inﬂuenza A&B (Binax, UK) for detection of
inﬂuenza A virus in nasopharygneal swab by using RT-PCR as the
standard method.
Method: Patients with a inﬂuenza-like illness admitted at Khon
Kaen Hospital between January 1, 2005, and October 31, 2007,
were considered for this study. Samples were collected with
informed consent. In total, 50 suspected cases with nasopha-
ryngeal swab samples were available for the study. The clinical
beneﬁt of the rapid test was evaluated by comparing the results
with standard method RT-PCR.
Result: The prevalences of inﬂuenza A positive in 50 cases
measured by rapid test and RT-PCR are 23.8% and 66.7%. The sen-
sitivity, speciﬁcity, positive predictive value, negative predictive
value and prevalence are 83.33% (95%CI 51.5-91.9), 100% (95%CI
88.4-100), 100% (95%CI 69.1-100), 93.75% (95%CI 79.2-99.2) and
28.57% (95%CI 15.7-44.6) respectively.
Conclusion: The ﬁnding that the sensitivity of rapid test was
slightly low when compared with standard method RT-PCR. There
may depend on many factors including the method of specimen
collection, the test method used, geographic location, and the
disease prevalence in speciﬁc localities. In addition, the impor-
tant properties of diagnostic tests that need to considered are
analytical sensitivity and analytical speciﬁcity.
OL-047 A combinatorial antiviral approach against
inﬂuenza A virus using ribozyme and siRNA
Madhu Khanna*,1,2, Vikas Sood3, Akhil Banerjea3,
Prashant Kumar3. 1VP Chest Institute; 2University of Delhi;
3National Institute of Immunology, New Delhi
Background: Recent advances in antisense technology have
emerged as a ray of hope against many pathogens. Latest fad
